| Literature DB >> 32560388 |
Camila Fernanda Zorzella Creste1,2, Patrícia Rodrigues Orsi1, Fernanda Cruz Landim-Alvarenga3, Luis Antônio Justulin4, Marjorie de Assis Golim2, Benedito Barraviera1,2, Rui Seabra Ferreira1,2.
Abstract
Fibrin scaffold fits as a provisional platform promoting cell migration and proliferation, angiogenesis, connective tissue formation and growth factors stimulation. We evaluated a unique heterologous fibrin biopolymer as scaffold to mesenchymal stem cells (MSCs) to treat a critical-size bone defect. Femurs of 27 rats were treated with fibrin biopolymer (FBP); FBP + MSCs; and FBP + MSC differentiated in bone lineage (MSC-D). Bone repair was evaluated 03, 21 and 42 days later by radiographic, histological and scanning electron microscopy (SEM) imaging. The FBP + MSC-D association was the most effective treatment, since newly formed Bone was more abundant and early matured in just 21 days. We concluded that FBP is an excellent scaffold for MSCs and also use of differentiated cells should be encouraged in regenerative therapy researches. The FBP ability to maintain viable MSCs at Bone defect site has modified inflammatory environment and accelerating their regeneration.Entities:
Keywords: biomaterial; bioproduct; fibrin; scaffold; stem cell
Year: 2020 PMID: 32560388 DOI: 10.3390/ma13122747
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623